Study finds shifts in treatment trends prior to publication of study results

The oral presentation of data from a single study at a national scientific conference can have an important impact on patient treatment, even before study publication or Food and Drug Administration (FDA) approval, according to a study in the March 15 issue of the Journal of the National Cancer Institute.

Specifically, the authors found that use of the chemotherapy drugs called taxanes increased after the May 1998 annual meeting of the American Society of Clinical Oncology (ASCO) where preliminary data were presented suggesting that use of taxanes as adjuvant therapy could improve survival in women with lymph node-positive breast cancer.

Results from the Cancer and Leukemia Group B (CALGB) Study 9344 suggested that adjuvant treatment with the taxane drug paclitaxel is associated with improved survival in women with lymph node-positive breast cancer. The results were first presented at the 1998 ASCO meeting. Although paclitaxel had been approved by the FDA in 1994 for the treatment of women with metastatic breast cancer, FDA approval for this new use of paclitaxel for women with node-positive breast cancer did not come until October 1999. A final report of CALGB Study 9344 was published in 2003. However, the preliminary results of the study presented in May 1998 were highlighted in news stories published in numerous major media outlets, including the New York Times, Wall Street Journal, and U.S. News and World Report.

To investigate the impact of the meeting presentation on practice patterns, Sharon H. Giordano, M.D., at the University of Texas M.D. Anderson Cancer Center, and colleagues studied chemotherapy use in 3341 women older than age 65, identified in the Surveillance, Epidemiology, and End Results-Medicare database, who were diagnosed with stage I-III breast cancer between 1994 and 1999 and received adjuvant chemotherapy within 1 year of diagnosis. The authors examined the use of taxanes among these women.

Contact: Ariel Whitworth
Journal of the National Cancer Institute

Page: 1 2 3

Related biology news :

1. Study begins to reveal clues to the cause and progression of sepsis
2. Study finds gender differences in renal and other genes contributing to blood pressure
3. Study suggests estrogen deficiency can lead to obesity-induced high blood pressure after menopause
4. Study: Sticking to the sand might not be such good, clean fun for beachgoers
5. Study points to new way to predict death risk from torn aorta
6. Study identifies new gene therapy tools for inherited blindness
7. Study finds contaminated water reaching Floridas offshore keys
8. Study sheds light on why humans walk on two legs
9. Study explains how pathogens evolve to escape detection
10. Study finds hereditary link to premenstrual depression
11. Study identifies energy efficiency as reason for evolution of upright walking

Post Your Comments:

(Date:11/2/2019)... ... 2019 , ... Stay on top of current hot topics through free webinars ... webinars is free, so be sure to register today to save your place! Participate ... to see our upcoming webinars: , CLINICAL OPERATIONS , November 14 – Leveraging Technology ...
(Date:10/30/2019)... ... October 30, 2019 , ... The 2019 Precision ... in which participants will learn about precision agriculture tools used to enhance beef ... , Participants will have the opportunity to visit Virginia Tech’s agricultural research ...
(Date:10/30/2019)... ... October 30, 2019 , ... Amberdata Inc., the ... firms, including Fenbushi Capital, DF Capital, Rising Tide Fund, and HWVP. The ... to further accelerate its position as the leading data provider of institutional-grade blockchain ...
Breaking Biology News(10 mins):
(Date:10/29/2019)... ... October 28, 2019 , ... CaroGen Corporation , a ... , Professor Jack R Wands, MD, of Brown University , ... Professor Gil Mor, MD, PhD, of Wayne State University, formerly a professor ...
(Date:10/29/2019)... ... 29, 2019 , ... Researchers at Sony recently demonstrated biometric ... imagers , researchers identified people by the image of a small patch on ... recognition, fingerprints and vasculature. , The new CMS4 series of cameras offer ...
(Date:10/22/2019)... ... October 22, 2019 , ... nQ Medical, Inc. of ... 2019 Most Fundable Companies List which was announced at a showcase event yesterday in ... in annual revenue, strong business plans, and impressive near-term growth projections to be named ...
(Date:10/22/2019)... LOS ANGELES (PRWEB) , ... October 22, 2019 ... ... software provider, today announced integration of the Alertus Mass Notification System into its ... critical infrastructure to the Enplug platform, making it possible for users to leverage ...
Breaking Biology Technology:
Cached News: